CoChat

Molecular MRI enables early and sensitive detection of brain metastases

Open access
Serres, Sébastien, Soto, Manuel Sarmiento, Hamilton, Alastair, McAteer, Martina A., Carbonell, W. Shawn, Robson, Matthew D., Ansorge, Olaf, Khrapitchev, Alexandre, Bristow, Claire, Balathasan, Lukxmi, Weissensteiner, Thomas, Anthony, Daniel C., Choudhury, Robin P., Muschel, Ruth J., Sibson, Nicola R. · 2012 · Proceedings of the National Academy of Sciences
Cited by 148

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Metastasis to the brain is a leading cause of cancer mortality. The current diagnostic method of gadolinium-enhanced MRI is sensitive only to larger tumors, when therapeutic options are limited. Earlier detection of brain metastases is critical for improved treatment. We have developed a targeted MRI contrast agent based on microparticles of iron oxide that enables imaging of endothelial vascular cell adhesion molecule-1 (VCAM-1). Our objectives here were to determine whether VCAM-1 is up-regulated on vessels associated with brain metastases, and if so, whether VCAM-1–targeted MRI enables early detection of these tumors. Early up-regulation of cerebrovascular VCAM-1 expression was evident on tumor-associated vessels in two separate murine models of brain metastasis. Metastases were detectable in vivo using VCAM-1–targeted MRI 5 d after induction (<1,000 cells). At clinical imaging resolutions, this finding is likely to translate to detection at tumor volumes two to three orders of magnitude smaller (0.3–3 × 10 5 cells) than those volumes detectable clinically (10 7 –10 8 cells). VCAM-1 expression detected by MRI increased significantly ( P < 0.0001) with tumor progression, and tumors showed no gadolinium enhancement. Importantly, expression of VCAM-1 was shown in human brain tissue containing both established metastases and micrometastases. Translation of this approach to the clinic could increase therapeutic options and change clinical management in a substantial number of cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1117412109

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 148

Metadata

Authors
Serres, S., Soto, M. S., Hamilton, A., McAteer, M. A., Carbonell, W. S., Robson, M. D., Ansorge, O., Khrapitchev, A., Bristow, C., Balathasan, L., Weissensteiner, T., Anthony, D. C., Choudhury, R. P., Muschel, R. J., & Sibson, N. R.
Venue
Proceedings of the National Academy of Sciences
Published
2012-03-26
Volume
109
Issue
17
Pages
6674-6679
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2019495672
Cited by
148
References
1
FWCI
12.02
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular MRI enables early and sensitive detection of brain metastases. https://app.cochat.ai/papers/10.1073/pnas.1117412109
The paper
Serres, S., Soto, M. S., Hamilton, A., McAteer, M. A., Carbonell, W. S., Robson, M. D., Ansorge, O., Khrapitchev, A., Bristow, C., Balathasan, L., Weissensteiner, T., Anthony, D. C., Choudhury, R. P., Muschel, R. J., & Sibson, N. R. (2012). Molecular MRI enables early and sensitive detection of brain metastases. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1117412109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.